Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lactate dehydrogenase A is a diagnostic biomarker associated with immune infiltration, m6A modification and ferroptosis in endometrial cancer

8 Nov 2024

Abstract excerpt

Background Lactate dehydrogenase A (LDHA) has been confirmed as a tumor promoter in various cancers, but its role in endometrial cancer remains unclear. Methods The Cancer Genome Atlas (TCGA), quantitative real-time polymerase chain reaction and the Human Protein Atlas were utilized to analyzed the LDHA expression in EC. The LDHA levels of patients with different clinical features were compared based on the TCGA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39582531
DOI: 10.3389/fonc.2024.1458344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lactate dehydrogenase A is a diagnostic biomarker associated with immune infiltration, m6A modification and ferroptosis in endometrial cancerPMID 39582531Read ↗

Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancerSemantic proximity Read ↗

Construction and Validation of a Ferroptosis-Related Prognostic Model for Endometrial CancerSemantic proximity Read ↗

Identification of clusters related to programmed cell death and potential prognostic biomarkers for immunotherapy response in endometrial cancerSemantic proximity Read ↗

Lactylation drives tumor microenvironment remodeling and immune evasion in esophageal cancer revealed by multiomics and single cell transcriptomicsSemantic proximity Read ↗

Lysine lactylation (Kla) might be a novel therapeutic target for breast cancerSemantic proximity Read ↗

Multi-omics analysis identifies lactylation-mediated immune biomarkers in esophageal cancerSemantic proximity Read ↗

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial CancerSemantic proximity Read ↗

Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of two redox-related genes associated with prognosis and immune microenvironment in endometrial carcinomaSemantic proximity Read ↗

Identification and validation of KIF23 as a hypoxia-regulated lactate metabolism-related oncogene in uterine corpus endometrial carcinoma.Semantic proximity Read ↗

Research on the Diagnostic Value and Immune Microenvironment Regulatory Mechanism of FOLR3 Gene in Endometrial Cancer Based on Multi-omics Data AlgorithmsSemantic proximity Read ↗

Lactate-related gene signatures predict prognosis and immune profiles in esophageal squamous cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.